BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29587299)

  • 1. Chronic Obstructive Pulmonary Disease in Lung Cancer Patients: Prevalence, Underdiagnosis, and Clinical Characterization.
    Mouronte-Roibás C; Leiro-Fernández V; Ruano-Raviña A; Ramos-Hernández C; Abal-Arca J; Parente-Lamelas I; Botana-Rial M; Priegue-Carrera A; Fernández-Villar A
    Respiration; 2018; 95(6):414-421. PubMed ID: 29587299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).
    Parrón Collar D; Pazos Guerra M; Rodriguez P; Gotera C; Mahíllo-Fernández I; Peces-Barba G; Seijo LM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1033-1038. PubMed ID: 28408813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of lung cancer in smokers with light and mild chronic obstructive pulmonary disease: a retrospective analysis of Japanese surgical cases.
    Kondo R; Yoshida K; Eguchi T; Kobayashi N; Saito G; Hamanaka K; Shiina T; Kurai M
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1439-43. PubMed ID: 21530296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD in primary lung cancer patients: prevalence and mortality.
    Ytterstad E; Moe PC; Hjalmarsen A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():625-36. PubMed ID: 27042050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underdiagnosis of chronic obstructive pulmonary disease in women: quantification of the problem, determinants and proposed actions.
    Ancochea J; Miravitlles M; García-Río F; Muñoz L; Sánchez G; Sobradillo V; Duran-Tauleria E; Soriano JB
    Arch Bronconeumol; 2013 Jun; 49(6):223-9. PubMed ID: 23317767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A retrospective study of diagnosis and treatment of chronic obstructive pulmonary disease in patients with lung cancer].
    Lin XF; Wang Q; Bai CX; Hong QY
    Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(40):2815-8. PubMed ID: 22333540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and management of pulmonary comorbidity in patients with lung and head and neck cancer.
    Gottlieb M; Marsaa K; Godtfredsen NS; Mellemgaard A
    Acta Oncol; 2015 May; 54(5):767-71. PubMed ID: 25907821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.
    Bárbara C; Rodrigues F; Dias H; Cardoso J; Almeida J; Matos MJ; Simão P; Santos M; Ferreira JR; Gaspar M; Gnatiuc L; Burney P
    Rev Port Pneumol; 2013; 19(3):96-105. PubMed ID: 23664024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.
    Young RP; Hopkins RJ; Christmas T; Black PN; Metcalf P; Gamble GD
    Eur Respir J; 2009 Aug; 34(2):380-6. PubMed ID: 19196816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study.
    Almagro P; Lapuente A; Pareja J; Yun S; Garcia ME; Padilla F; Heredia JL; De la Sierra A; Soriano JB
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1353-61. PubMed ID: 26213464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality Improvement Initiatives to Optimize the Management of Chronic Obstructive Pulmonary Disease in Patients With Lung Cancer.
    Digby GC; Robinson A
    J Oncol Pract; 2017 Nov; 13(11):e957-e965. PubMed ID: 28841364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.
    Mateu-Jimenez M; Curull V; Pijuan L; Sánchez-Font A; Rivera-Ramos H; Rodríguez-Fuster A; Aguiló R; Gea J; Barreiro E
    J Thorac Oncol; 2017 Feb; 12(2):235-248. PubMed ID: 27793775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIAGNOSTIC AND TACTICAL IMPORTANCE OF STUDYING SHORT CHAIN FATTY ACIDS IN DIFFERENT BIOLOGICAL SUBSTRATES TOOK PLACE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, LUNG CANCER AND COMMUNITY-ACQUIRED PNEUMONIA DEVELOPED AFTER ANTICANCER THERAPY.
    Ardatskaya MD; Ponomareva EV; Shevtsov VV; Evdokimova SA; Odintsov SV
    Eksp Klin Gastroenterol; 2016; (11):17-25. PubMed ID: 29889440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Wang C; Xu J; Yang L; Xu Y; Zhang X; Bai C; Kang J; Ran P; Shen H; Wen F; Huang K; Yao W; Sun T; Shan G; Yang T; Lin Y; Wu S; Zhu J; Wang R; Shi Z; Zhao J; Ye X; Song Y; Wang Q; Zhou Y; Ding L; Yang T; Chen Y; Guo Y; Xiao F; Lu Y; Peng X; Zhang B; Xiao D; Chen CS; Wang Z; Zhang H; Bu X; Zhang X; An L; Zhang S; Cao Z; Zhan Q; Yang Y; Cao B; Dai H; Liang L; He J;
    Lancet; 2018 Apr; 391(10131):1706-1717. PubMed ID: 29650248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early-stage COPD.
    Kim ES; Kim YT; Kang CH; Park IK; Bae W; Choi SM; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Kim YW; Han SK; Yoo CG
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1317-26. PubMed ID: 27366059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
    Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
    Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.